When health care providers enter high-value acquisitions to expand patient access and scale operations nationally, Kevin Ryan offers regulatory and due diligence counsel to ensure deal integrity. Kevin’s focus on the business of health care includes the corporate practice of medicine and telehealth. Clients value the former hospital executive and managed care company general counsel’s practical, bottom-line solutions and experience with all medical specialties. Kevin represents private equity firms and health care providers—from startups to large national corporations.
During transactions, Kevin examines all health regulatory issues connected to an acquisition—licensing, policies, procedures, Medicare, Medicaid, privacy, security, and more. Clients rely on Kevin to oversee multiple agency approvals and prevent costly regulatory liabilities in these complex, multistate deals. He has collaborated with national deal teams involving private equity acquisitions of specialty pharmacies, ophthalmology services, radiology companies, and other providers.
In addition, Kevin advises telemedicine clients on new obligations and opportunities spurred by the COVID-19 pandemic. He develops corporate compliant structures and 50-state regulatory strategies. Drawing upon four decades of experience addressing scope of practice issues for nurse practitioners, dentists, physical therapists, mental health therapists, and others, Kevin provides timely and actionable answers to emerging regulatory challenges. Kevin is the author a chapter in the book Corporate Practice of Medicine: A Fifty State Survey, published by the American Health Lawyers Association.